| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |